http://www.apellis.com
Apellis Pharmaceuticals, Inc. Company Intro
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
Industry
Healthcare
Apellis Pharmaceuticals, Inc. Headquaters
6400 Westwind Way
Crestwood,40014
United States
Apellis Pharmaceuticals, Inc. Share price
14 Sep 2022 08:37 GMT
$66.50
-0.77 (-1.14 %)
Apellis Pharmaceuticals, Inc. Market cap
$7.147 B
WMC RANKING
2023
Apellis Pharmaceuticals, Inc. # 36
BiotechnologyLatest Apellis Pharmaceuticals, Inc. News
25 Mar 2023
Cedric Francois Sells 30000 Shares of Apellis ...
Apellis Pharmaceuticals, Inc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds...
25 Mar 2023
Cedric Francois Sells 30000 Shares of Apellis ...
Apellis Pharmaceuticals, Inc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds...
24 Mar 2023
Cold Agglutinin Disease Medicine Market Analysis Massive ...
Cold Agglutinin Disease Medicine Market Analysis Massive ...
WMC Market Score
WMC Market to Revenue Score
Apellis Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Apellis Pharmaceuticals, Inc. | USD | $250,646 | $465,127 | $-359,711 | $71,470B | 36 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Apellis Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Apellis Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Apellis Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Apellis Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Apellis Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Apellis Pharmaceuticals, Inc. | 4.00 | 9.82 | 0.04 | 0 | 0 | 0 | 4.44 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 22 | 0 | 0 | 9.75 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 33 | 0 | 0 | 14.66 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 43.17 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
